News
-
-
PRESS RELEASE
Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation
Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose a Combination Transaction to reverse bankruptcy procedures, with conditions and a financing transaction. The combined entity will focus on drug development for speciality medicines. The planned transaction is subject to various approvals and closing conditions -
PRESS RELEASE
EQS-Adhoc: PIERER Mobility: 2023 – Strong year in the motorcycle segment – Restructuring in the bicycle segment underway
PIERER Mobility AG reports a strong year in the motorcycle segment with restructuring in the bicycle segment underway. New record sales of EUR 2,661 million and EBIT of EUR 160 million in 2023. Outlook for 2024 focuses on increasing profitability and strengthening the core business -
-
-
PRESS RELEASE
Good profitability in a difficult economic environment
Interroll Holding AG announces good profitability despite challenging economic environment for the full financial year 2023. EBITDA and EBIT margins expected to be slightly below 2022/2021. Sales and order intake declined, impacted by negative currency effects and weak demand -
-
PRESS RELEASE
ROSEN, A LONGSTANDING LAW FIRM, Encourages British American Tobacco p.l.c Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BTI
The Rosen Law Firm has filed a class action lawsuit against British American Tobacco p.l.c. for its investors. The firm encourages investors to secure counsel before the March 25, 2024 deadline. The lawsuit alleges that the company understated risks related to its Premium American Cigarette Brands, causing damages to investors -
PRESS RELEASE
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages B. Riley Financial, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RILY
Rosen Law Firm files class action lawsuit on behalf of B. Riley Financial, Inc. investors for securities fraud. Investors may be entitled to compensation and should secure qualified counsel before March 25, 2024 deadline -
PRESS RELEASE
ROSEN, A TOP RANKED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
Rosen Law Firm, a global investor rights law firm, reminds Eagle Pharmaceuticals, Inc. investors of February 9, 2024 lead plaintiff deadline in securities class action. The lawsuit claims investors suffered damages due to false and misleading statements
